January 27th 2021, 10:00pm
A 13.9% increase in diagnosed cases of HIV was seen following expansion of Medicaid coverage under the Affordable Care Act.
January 27th 2021, 3:30pm
Telemedicine sprang up very quickly and will stay around to some extent once the pandemic ends, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.
January 27th 2021, 1:46pm
The American College of Rheumatology (ACR) announced a number of policy priorities that it is encouraging the new Congress and administration to focus on during the year.
January 26th 2021, 11:15pm
On this episode, we speak with the coauthor of a paper looking at the mental health stressors facing first responders and health care workers during the coronavirus disease 2019 (COVID-19) pandemic. The paper found that a sizable number of these frontline workers are at risk for psychiatric illnesses at severity levels higher than other national disasters, including 9/11 and Hurricane Katrina.
January 26th 2021, 8:09pm
Periodic review of treatment safety and monitoring are necessary as medical centers increasingly use newer disease-modifying therapies earlier in the course of multiple sclerosis.
January 26th 2021, 3:30pm
President Joe Biden reportedly will take executive action to reopen federal marketplaces selling Affordable Care Act (ACA) health plans; Moderna investigating booster shot designed to be more effective against emerging variants of coronavirus disease 2019 (COVID-19); Brazil coronavirus variant is found in Minnesota.
January 25th 2021, 10:30pm
Breast cancer oncologists explore more recent advances using oral chemotherapies to treat metastatic breast cancer.
January 25th 2021, 10:12pm
Voclosporin, the first FDA-approved oral therapy for lupus nephritis, will be sold as Lupkynis by Aurinia Pharmaceuticals and is approved for use in conjunction with immunosuppressive treatment.
January 25th 2021, 9:20pm
Metabolic surgery is more effective than conventional medical therapy in the long-term control of type 2 diabetes (T2D), according to results of a 10-year follow-up study of a randomized controlled trial published in The Lancet.
January 24th 2021, 1:00pm
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
